A secondary prevention lipid clinic reaches low-density lipoprotein cholesterol goals more often than usual cardiology care with coronary heart disease

Journal of Clinical Lipidology

Volumn 4, Issue 1, 2010, Pages 46-52

  Birtcher, Kim K ^a   Greisinger, Anthony J ^b   Brehm, Brenda J ^b   Wehmanen, Oscar A ^b   Furman, Loriann M ^c   Salinas, Cathryn C ^c   Mirzai Tehrane, Madjid ^c   Nayak, Atasu ^c   Rashid, Haroonur ^c   Mortazavi, Ali ^c  

^a UNIVERSITY OF HOUSTON   (United States)

^b Kelsey Research Foundation   (United States)

^c Kelsey Seybold Clinic   (United States)

Author keywords

Coronary artery disease; Guideline adherence; LDL C goal; Lipid clinic; Multidisciplinary clinic; NCEP guidelines; Pharmacist; Prevention; Quality improvement

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY CARE UNIT; DIET THERAPY; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MOTIVATION; NUTRIENT MANAGEMENT; NUTRITIONAL VALUE; PATIENT ASSESSMENT; PATIENT CARE; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; SECONDARY PREVENTION; TREATMENT OUTCOME;

AGED; AMBULATORY CARE FACILITIES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COHORT STUDIES; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SECONDARY PREVENTION; TRIGLYCERIDES;

EID: 75749152623     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2009.12.001     Document Type: Article

References (38)

1. American Heart Association. Heart Disease and Stroke Statistics-2008 Update (2008), American Heart Association, Dallas, TX
2. National Cholesterol Education Panel, Adult Treatment Panel III. JAMA 285 (2001) 2486-2497
3. Grundy S.M., Cleeman J.I., Merz C.N., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol 44 (2004) 720-732
4. Smith Jr. S.C., Allen J., and Blair S.N. AHA/ACC; National Heart, Lung and Blood Institute. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung and Blood Institute. Circulation 113 (2006) 2363-2372
5. LaRosa J.C., and Cleeman J.I. Cholesterol lowering as a treatment for established coronary heart disease. Circulation 85 (1992) 1229-1235
6. Brown B.G., Zhao X.Q., Sacco D.E., and Albers J.J. Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease. Circulation 87 (1993) 1781-1791
7. Strechtman G., and Hiatt J. Drug therapy for hypercholesterolemia in patients with cardiovascular disease: Factors limiting achievement of lipid goals. Am J Med 100 (1996) 197-204
8. The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (JNC VI). Arch Inter Med 157 (1997) 2413-2446
9. Chobanian A.V., Bakris G.L., Black H.R., et al. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 (2003) 1206-1252
10. The Vesthold Heartcare Study Group. Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention programme in patients with coronary heart disease. Eur J Cardiovasc Prev Rehabil 10 (2003) 429-437
11. McLeod A.L., Brooks L., Taylor V., Currie P.F., and Dewhurst N.G. Secondary prevention for coronary artery disease. Q J Med 97 (2004) 127-131
12. Meade L.T. Barriers to Achieving LDL cholesterol goals. US Pharmacist 32 (2007) 66-71
13. Mazzolini T.A., Irons B.K., Schell E.C., and Seifer C.F. Use of lipid-lowering drugs for patients in pharmacist-managed lipid clinics versus usual care in 2 VA medical centers. J Manag Care Pharm 11 (2005) 763-771
14. Schectman G., Wolff N., Byrd J.C., Hiatt J.G., et al. Physician extenders for cost-effective management of hypercholesterolemia. J General Intern Med 11 (1996) 277-286
15. Shaffer J., and Wexler J. Reducing low-density lipoprotein cholesterol levels in an ambulatory care system: results of a multidisciplinary collaborative practice lipid clinic compared with traditional physician-based care. Arch Intern Med 155 (1995) 2330-2335
16. Blum B.M., McKenney J.M., and Cziraky M.J. Pharmaceutical care services and results in Project ImPACT: hyperlipidemia. J Am Pharm Assoc 40 (2000) 157-165
17. Brown A.S., and Cofer L.A. Lipid management in a private cardiology practice (the Midwest heart experience). Am J Cardiol 85 (2000) 18A-22A
18. Merenich J.A., Lousberg T.R., Brennan S.H., et al. Optimizing treatment of dyslipidemia in patients with coronary artery disease in a managed care environment. Am J Cardiol 85 (2000) 36A-42A
19. Vivian E. Improving blood pressure control in a pharmacist-managed hypertension clinic. Pharmacotherapy 22 (2002) 1533-1540
20. Tsuyuki R.T., Johnson J.A., Teo K.K., et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the study of cardiovascular risk intervention by pharmacists (SCRIP). Arch Intern Med 162 (2002) 1149-1155
21. Faulkner M.A., Wadibia E.C., Lucus B.D., and Hilleman D.E. Impact of pharmacy counseling on compliance and effectiveness of combination of lipid-lowering therapy in patients undergoing coronary artery revascularization, a randomized controlled clinical trial. Pharmacotherapy 20 (2000) 410-416
22. O'Donnell D.C., Chen W.T., and Piziak V.K. Goal attainment and maintenance of serum cholesterol level in a pharmacist-coordinated lipid clinic. Am J Health Systems Pharmacists 58 (2001) 325-330
23. Cording M.A., Engelbrecht-Zadvorny E.B., Pettit B.J., Eastham J.H., et al. Development of a pharmacist-managed lipid clinic. Ann Pharmacother 36 (2002) 892-904
24. Till L.T., Voris J.C., and Horst J.B. Assessment of clinical pharmacist management of lipid-lowering therapy in a primary care setting. J Manag Care Pharm 9 (2003) 269-273
25. Borenstein J.D., Graber G., Saltiel E., Walace J., et al. Physician-pharmacist comanagement of hypertension: a randomized, comparative trial. Pharmacotherapy 23 (2003) 209-216
26. Olson K.L., Rasmussen J., and Sandhoff B.G. Merenich JA for the Clinical Pharmacy Cardiac Risk Service (CPCRS) Study Group. Lipid Management in Patients with Coronary Artery Disease by a Clinical Pharmacy Service in a Group Model Health Maintenance Organization. Arch Intern Med 165 (2005) 49-54
27. Collins C., Kramer A., O'Day M.E., and Low M.B. Evaluation of patient and provider satisfaction with a pharmacist-managed lipid clinic in a Veterans Affairs medical center. Am J Health-Syst Pharm 63 (2006) 1723-1727
28. Becker D.M., Raquerno J.V., Yook R.M., et al. Nurse-mediated cholesterol management compared with enhanced primary care in siblings of individuals with premature coronary disease. Arch Intern Med 158 (1998) 1533-1539
29. Murchie P., Campbell N.C., Ritchie L.D., Simpson J.A., et al. Secondary prevention clinics for coronary heart disease: four year follow up of a randomized controlled trial in primary care. BMJ 326 (2003) 84
30. Robinson J.G., Conroy C., and Wickemeyer W.J. A novel telephone-based system for management of secondary prevention to a low-density lipoprotein cholesterol <100mg/dL. Am J Cardiol 85 (2000) 305-308
31. Mainie P.M., Moore G., Riddell J.W., and Adgey A.A. To examine the effectiveness of a hospital-based nurse-led secondary prevention clinic. Eur J Cardiovasc Nurs 4 (2005) 308-313
32. Berna G.M.S., van der Bijl J.J., Banga J.D., and Visseren F.L.J. Vascular risk management through nurse-led self-management programs. J Vasc Nurs 23 (2005) 20-24
33. American Heart Association. How Do I Follow A Healthy Diet? c2007. Available at: http://www.americanheart.org/presenter.jhtml?identifier=3004832. Accessed December 8, 2009
34. American Heart Association. Why Should I Be Physically Active? c2007. Available at: http://www.americanheart.org/presenter.jhtml?identifier=3009620. Accessed December 8, 2009
35. American Heart Association. How Can I Quit Smoking? c2007. Available at: http://www.americanheart.org/presenter.jhtml?identifier=3004837. Accessed December 8, 2009
36. Chou A.F., Hudson Scholle S., et al. Gender disparities in the quality of cardiovascular disease care in private managed care plans. Women's Health Issues 17 (2007) 120-130
37. Shammas N.W., Lemke J.H., Deckert J., Toth P.P., McKinney D., and Dippel E.J. Gender differences in adhering to national guidelines in a community lipid clinic. Prev Cardiol 9 (2006) 215-218
38. Santos R.D., Waters D.D., Tarasenko L., et al. on behalf of the L-TAP 2 investigators. Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: the Lipid Treatment Assessment Project (L-TAP) 2. Am Heart J 158 (2009) 860-866